A revolutionary immunotherapy has stunned doctors by making an aggressive, previously incurable blood cancer vanish in some ...

What to know about new diagnostic tools, targeted medications, and other recent advances in the treatment of metastatic NSCLC ...

Karen Eubanks Jackson has reshaped the conversation around breast cancer for Black women in America—and now, with the ASCO ...

The study adds to growing evidence that digital tools can maximize genetic counselors' limited time without patient harm.

A new FDA application for vepdegestrant offers hope for advanced breast cancer patients with ESR1 mutations, showcasing ...

Research suggests women with high breast cancer risk and menopausal symptoms could benefit from Duavee, which reduced breast tissue cell growth in a Northwestern University study.

New research presented at the 2025 American Society for Clinical Oncology’s (ASCO) annual meeting has shed light on the ...

Colorectal cancer offered the earliest window into the trend of increased cancer incidence among those younger than age 50.

Each year, the American Society of Clinical Oncology annual meeting brings together the biggest names and brightest minds in ...

Multiple myeloma is considered incurable, but a third of patients in a clinical trial have lived without detectable cancer for years, after facing certain death ...

An artificial intelligence-based tool identifies patients with high-risk, nonmetastatic prostate cancer (PCa) who would most likely benefit from treatment intensification, an investigator reported at ...

Prespecified subgroup analyses showed that primary surgery conferred greater benefits for patients with stage III disease and ...